2009 Fiscal Year Final Research Report
Adaptation of the most suitable anticancer drug by utilizing new developed three-dimensional model mimicked human tumor microenvironment.
Project/Area Number |
20790295
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Single-year Grants |
Research Field |
Experimental pathology
|
Research Institution | Hokkaido University |
Principal Investigator |
TSUDA Masumi Hokkaido University, 大学院・医学研究科, 助教 (30431307)
|
Project Period (FY) |
2008 – 2009
|
Keywords | 腫瘍微小環境 / 抗がん剤 |
Research Abstract |
We identify receptor activator of nuclear factor κB ligand (RANKL) as a microenvironment-specific factor essential for tumorigenesis in vivo, utilizing oral squamous cell carcinoma as a model. In addition, in human synovial sarcoma that frequently occurs pulmonary metastasis, the interaction between the tumor and endothelial cells is important for tumor angiogenesis. Src family kinase inhibitor impaired this angiogenesis effectively.
|
Research Products
(8 results)